Federation Des Caisses Desjardins Du Quebec Novo Cure LTD Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $23.7 Billion
  • Q3 2025

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Novo Cure LTD stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 1,979 shares of NVCR stock, worth $22,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,979
Previous 1,979 -0.0%
Holding current value
$22,402
Previous $35,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.83 - $24.05 $201,299 - $409,234
-17,016 Reduced 89.58%
1,979 $33,000
Q1 2024

May 15, 2024
BUY
$12.42 - $17.29 $235,917 - $328,423
18,995 New
18,995 $285 Million
Q4 2023

Aug 14, 2024
BUY
$11.13 - $15.78 $1,335 - $1,893
120 Added 0.64%
18,995 $284 Million
Q2 2023

Aug 14, 2024
SELL
$40.29 - $82.51 $345,768 - $708,100
-8,582 Reduced 31.26%
18,875 $783 Million
Q1 2023

Aug 14, 2024
BUY
$56.44 - $118.81 $1.44 Million - $3.04 Million
25,598 Added 1376.98%
27,457 $1.65 Billion
Q4 2022

Aug 14, 2024
SELL
$63.98 - $85.37 $1.64 Million - $2.19 Million
-25,598 Reduced 93.23%
1,859 $136 Million
Q1 2022

Aug 14, 2024
BUY
$60.15 - $84.52 $1.53 Million - $2.15 Million
25,478 Added 1287.42%
27,457 $2.27 Billion
Q4 2021

Aug 30, 2024
SELL
$75.08 - $121.99 $398,674 - $647,766
-5,310 Reduced 17.23%
25,512 $1.91 Billion
Q3 2021

Aug 30, 2024
SELL
$116.17 - $194.55 $151,834 - $254,276
-1,307 Reduced 4.07%
30,822 $3.58 Billion
Q2 2021

Aug 30, 2024
BUY
$130.4 - $225.58 $3.93 Million - $6.8 Million
30,150 Added 1523.5%
32,129 $7.12 Billion
Q1 2021

Aug 30, 2024
SELL
$124.11 - $190.17 $1.04 Million - $1.59 Million
-8,366 Reduced 20.26%
32,927 $4.35 Billion
Q4 2020

Aug 30, 2024
BUY
$112.16 - $174.14 $75,932 - $117,892
677 Added 1.67%
41,293 $7.15 Billion
Q3 2020

Aug 30, 2024
SELL
$58.05 - $111.31 $420,282 - $805,884
-7,240 Reduced 15.13%
40,616 $4.53 Billion
Q1 2020

Aug 30, 2024
BUY
$57.05 - $95.75 $221,639 - $371,988
3,885 Added 8.84%
47,856 $3.26 Billion
Q2 2019

Aug 30, 2024
BUY
$42.22 - $63.23 $177,788 - $266,261
4,211 Added 10.59%
43,971 $2.77 Billion
Q1 2019

Aug 30, 2024
BUY
$31.96 - $56.12 $1.14 Million - $2 Million
35,671 Added 872.36%
39,760 $1.92 Billion
Q4 2018

Aug 30, 2024
BUY
$28.72 - $52.63 $60,599 - $111,049
2,110 Added 106.62%
4,089 $137 Million
Q2 2017

Aug 30, 2024
SELL
N/A
-200 Reduced 9.14%
1,988 $34.4 Million
Q1 2017

Aug 30, 2024
BUY
N/A
209
2,188 $17.7 Million

Others Institutions Holding NVCR

# of Institutions
290
Shares Held
75.2M
Call Options Held
1.26M
Put Options Held
247K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.19B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email